You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Transcatheter arterial chemoembolization

Showing 1 - 25 of 6,540
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Guangzhou (Bevacizumab combined with Sintilimab, Transcatheter arterial chemoembolization)

Recruiting
  • Hepatocellular Carcinoma
  • Bevacizumab combined with Sintilimab
  • Transcatheter arterial chemoembolization
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Oct 14, 2023

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Nanjing (Oxycodone, Sufentanil)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 15, 2023

Patterns of Transcatheter Arterial Chemoembolization Combined

Not yet recruiting
  • HCC
  • (no location specified)
Aug 29, 2023

Hepatocellular Carcinoma Trial (TACE(transcatheter arterial chemoembolization), lenvatinib, Icaritin soft capsules)

Not yet recruiting
  • Hepatocellular Carcinoma
  • TACE（transcatheter arterial chemoembolization）
  • +2 more
  • (no location specified)
Jun 5, 2023

Hepatocellular Carcinoma, Transcatheter Arterial ChEmoembolization, Regorafenib Trial in Guangzhou (TACE, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    FirstSunYetSen
Apr 12, 2023

Tumor Micronecrosis on Postoperative Transcatheter Arterial

Completed
  • Carcinoma, Hepatocellular
  • transcatheter arterial chemoembolization
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, Zhejiang University School of Med
Apr 22, 2022

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Chongqing (Esketamine, Sufentanil)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jan 2, 2023

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors

Not yet recruiting
  • Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
  • HX008 + TACE
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer hospital
Dec 8, 2022

Hepatocellular Carcinoma Trial in Seoul (Nexsphere™)

Recruiting
  • Hepatocellular Carcinoma
  • Nexsphere™
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 1, 2022

Advanced Gastric Cancer Trial in Shanghai (Transcatheter Arterial Chemoembolization, Tislelizumab)

Recruiting
  • Advanced Gastric Cancer
  • Shanghai, Shanghai, China
    ZhongShan hospital Fudan university
May 25, 2022

Colorectal Cancer Liver Metastasis Trial (Irinotecan and polyvinyl alcohol sodium acrylate embolization

Not yet recruiting
  • Colorectal Cancer Liver Metastasis
  • Irinotecan and polyvinyl alcohol sodium acrylate embolization microspheres（Unipearls®）
  • Irinotecan and HepaSphere Microspheres
  • (no location specified)
Aug 31, 2023

Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

Recruiting
  • Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    Guoliang Shao
Aug 1, 2023

Advanced Hepatocellular Carcinoma Trial in Chengdu (Lenvatinib combined with TACE and Camrelizumab)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Lenvatinib combined with TACE and Camrelizumab
  • Chengdu, Sichuan, China
    HuaXi hospital
Feb 12, 2023

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (TACE combined with lenvatinib and sintilimab)

Completed
  • Hepatocellular Carcinoma Non-resectable
  • TACE combined with lenvatinib and sintilimab
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Nov 8, 2022

Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • I-125 Seeds Brachytherapy in PVTT
  • +2 more
  • (no location specified)
Aug 14, 2023

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (TACE combined with sorafenib and tislelizumab)

Completed
  • Hepatocellular Carcinoma Non-resectable
  • TACE combined with sorafenib and tislelizumab
  • Guangzhou, Guangdong, China
  • +1 more
Oct 11, 2022

Hepatocellular Carcinoma Trial in Houston (Lenvatinib, Transcatheter Arterial Chemoembolization)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Houston, Texas
    Houston Methodist Research Institute
Dec 10, 2021

Hepatocellular Carcinoma Trial in Shanghai (Sintilimab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Fudan University Shanghai Cancer Center
May 30, 2022

Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemo Trial in Chongqing (Esketamine,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jun 9, 2022

Hepatocellular Carcinoma Trial in Hershey (Lumason)

Completed
  • Hepatocellular Carcinoma
  • Hershey, Pennsylvania
    Penn State Hershey Medical Center
Oct 17, 2022

Comparison of Efficacy in SBRT of HCC =5 cm With or Without TACE

Recruiting
  • Small Hepatocellular Carcinoma
  • +2 more
  • transcatheter arterial chemoembolization
  • Beijing, China
    The Fifth Medical Center of PLA General Hospital (Beijing 302 ho
Sep 12, 2021

Hepatocellular Carcinoma, TACE, Anlotinib Trial in Lanzhou, Xi'an (Anlotinib Hydrochloride, TACE)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Anlotinib Hydrochloride
  • TACE
  • Lanzhou, Gansu, China
  • +3 more
Jan 12, 2023

Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,

Active, not recruiting
  • Radiomics
  • +4 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023

Comparison of Efficacy in SBRT of Large HCC With or Without TACE

Recruiting
  • Large HCC Patients
  • +2 more
    • Beijing, China
      Beijing 302 hospital
    Sep 12, 2021

    Hepatocellular Carcinoma Trial in Shanghai (lenvatinib, TACE)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Shanghai, China
      Huashan hospital
    Jul 29, 2022